Company description

Founded in 1997, Quinta-Analytica is an well recognized one-stop-shop company offering five main pillars of the business for worldwide pharmaceutical companies:

1) Pharmaceutical Analyses - research & development, analysis and testing, quality control, stability studies and more

2) Clinical Testing - in-house operating Clinical Unit provides with BE/BA/PK studies

3) Bioanalytical Testing - Complete integrated solution for GLP/GCP compliant BE studies and preclinical studies 

4) API Solution - identification and qualification of reliable API manufacturers 

5) Formulation - design and optimization of the formulation for various FDFs 

Quinta-Analytica was inspected by FDA more than 10 times already with no findings. Besides of above mentioned, we offers also expertise in batch release, analytics of inhalers, peptides and proteins (large molecule analyses generally including biosimilars) as well as consultancy in Regulatory and Clinical Strategy. We are located in Prague, Czech Republic.

Quinta-Analytica operates in full compliance with GCP/GLP/GMP and also FDA standards. 

Due to joint-venture laboratory located in Russia we can support our business partners also in terms of their needs of pre-clinical and clinical studies on Russian market.   

Quick facts

Sales markets Western Europe; Eastern Europe; North America
Affiliated categories: Analytical Chemistry |Analytical Development |Bio Analytical Services More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 4K52 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121B56 See our Exhibitor Profile   See full Exhibitor List
Quinta - Analytica

Contact information




View all contact information